Caruthers Regine L, Johnson Cary E
Pediatric Cardiothoracic Unit, University of Michigan Hospitals and Health Centers, Ann Arbor, MI 48109-0008, USA.
Am J Health Syst Pharm. 2007 Jul 15;64(14):1513-5. doi: 10.2146/ajhp060450.
In an effort to minimize barriers to compliance and adherence and to improve the accuracy of dosage measurement, sugar-containing and sugar-free sodium phenylbutyrate suspensions were formulated, and the stability of these products over a 90-day period was determined.
An oral suspension of sodium phenylbutyrate 200 mg/mL was prepared by thoroughly grinding 12 g of Sodium Phenylbutyrate Powder, USP, in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of each formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and were stored at room temperature. A 500-microL sample was withdrawn from each of the six bottles with a micropipette immediately after preparation and at 7, 14, 28, 60, and 90 days. After further dilution to an expected concentration of 100 microg/mL with the mobile phase, the samples were assayed by high-performance liquid chromatography. Stability was defined as the retention of at least 90% of the initial concentration.
At least 95% of the initial sodium phenylbutyrate concentration remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH and no visible microbial growth in any sample.
Extemporaneously compounded suspensions of sodium phenylbutyrate, 200 mg/mL, in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature.
为尽量减少依从性和坚持治疗的障碍,并提高剂量测量的准确性,配制了含糖和无糖的苯丁酸钠混悬液,并测定了这些产品在90天内的稳定性。
将12 g美国药典苯丁酸钠粉末在玻璃研钵中充分研磨,制备200 mg/mL的苯丁酸钠口服混悬液。将30 mL Ora-Plus和30 mL Ora-Sweet或Ora-Sweet SF混合,加入粉末中,最终体积为60 mL。每种制剂制备三个相同的样品,放入带有儿童安全盖的2盎司琥珀色塑料瓶中,室温保存。制备后立即以及在第7、14、28、60和90天,用微量移液器从六个瓶子中各取出500 μL样品。用流动相进一步稀释至预期浓度100 μg/mL后,通过高效液相色谱法对样品进行分析。稳定性定义为至少保留初始浓度的90%。
在整个90天的研究期间,两种制剂中苯丁酸钠的初始浓度至少保留了95%。任何样品的颜色、气味、味道和pH值均未检测到变化,也没有可见的微生物生长。
当在室温下储存在2盎司琥珀色塑料瓶中时,200 mg/mL的苯丁酸钠临时配制的混悬液在Ora-Plus与Ora-Sweet或Ora-Sweet SF的1:1混合物中至少稳定90天。